Retrospective analysis evaluating ovarian cancer cases presented at the clinical oncology department, Alexandria UniversityFootnote

Available online 9 August 2012

Footnote

Peer review under the responsibility of Alexandria University Faculty of Medicine.

References

• M.GarciaA.JemalE.M.WardGlobal cancer facts & figures2007American Cancer SocietyAtlanta GA
   Google Scholar
• H.T.LynchP.WatsonJ.F.LynchHereditary ovarian cancer. Heterogeneity in age at onsetCancer712 Suppl1993573581
   PubMed Web of Science ®Google Scholar
• R.F.OzolsR.C.YoungChemotherapy of ovarian cancer (review)Semin Oncol181991222232
   PubMed Web of Science ®Google Scholar
• A.J.DemboM.DavyA.E.StenwigPrognostic factors in patients with stage I epithelial ovarian cancerObstet Gynecol7521990263273
   PubMed Web of Science ®Google Scholar
• F.Y.AhmedE.WiltshawR.P.A’HernNatural history and prognosis of untreated stage I epithelial ovarian carcinomaJ Clin Oncol1411199629682975
   Web of Science ®Google Scholar
• M.MongaJ.A.CarmichaelW.E.ShelleySurgery without adjuvant chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical stagingGynecol Oncol4331991195197
   Web of Science ®Google Scholar
• I.VergoteC.G.TropéF.AmantNeoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancerN Engl J Med.363102010943953
   PubMed Web of Science ®Google Scholar
• Ibrahim Abd el-bar. Cancer in Egypt, Gharbiah. Triennial report of 2000–2002, Gharbiah population based cancer registry. 1st ed. 2007. ISBN:977-17-4932-3.
   Google Scholar
• Egypt National Cancer Registry, Aswan Profile-2008. Ministry of Communication and Information Technology.
   Google Scholar
• L.S.FreedmanS.Al-KayedM.B.QasemM.BarchanaM.BoyiadzisK.El-NajjarCancer registration in the Middle EastEpidemiology122001131133
   Web of Science ®Google Scholar
• M.F.PaesR.D.DaltoéK.P.MadeiraL.C.RezendeG.M.SirtoliA.L.HerlingerA retrospective analysis of clinicopathological and prognostic characteristics of ovarian tumors in the state Espritio SantoBraz J Ovarian Res92011414
   Google Scholar
• I.A.MalikA prospective study of clinco-pathological features of epithelial ovarian cancer in PakistanJ Pak Med Assoc522002155158
   Google Scholar
• C.M.SarwarN.SiddiquiR.A.KhokharF.BadarEpithelial ovarian cancer at a cancer hospital in a developing countryAsian Pac J Cancer Prev72006595598
   Google Scholar
• P.SinghI.ArunachalamP.SinghOvarian cancer in Oriental women from Singapore: disease pattern and survivalInt Surg7521990115122
   Web of Science ®Google Scholar
• S.SaeedM.AkramEpithelial ovarian cancer; epidemiology and clinicopathological featuresProf Med J1912012040045
   Google Scholar
• A.S.WongN.AuerspergOvarian surface epithelium: family history and early events in ovarian cancerReprod Biol Endocrinol1200370
   Google Scholar
• J.SehouliK.SavvatisE.BraicuPrimary versus interval debulking surgery in advanced ovarian cancer: Results from a systematic single-center analysisInt J Gynecol Cancer20201013311340
   Web of Science ®Google Scholar
• M.M.ThrallH.J.GrayR.G.SymonsTrends in treatment of advanced epithelial ovarian cancer in the Medicare populationGynecol Oncol12212011100106
   PubMed Web of Science ®Google Scholar
• C.G.GeresteinM.J.EijkemansJ.BakkerNomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancerAnticancer Res3111201140434049
   Web of Science ®Google Scholar
• A.H.BrandOvarian cancer debulking surgery: a survey of practice in Australia and New ZealandInt J Gynecol Cancer212011230235
   Web of Science ®Google Scholar
• P.LervolinoM.PalmieriM.RotondiBorderline ovarian tumors. Retrospective analysis of 20 casesJ Minerva Ginecol5320019799
   Google Scholar
• E.DaraiJ.TeboulF.WalkerBorderline ovarian tumors: a series of 43 patientsJ Contracept Fertil Sex25121997933938
   Google Scholar
• T.ThigpenR.VanceL.PunekyT.KhansurChemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trialsGynecol Oncol551994S97S107
   PubMed Web of Science ®Google Scholar
• J.P.NeijtS.A.EngelholmM.K.TuxenP.G.SorensenExploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancerJ Clin Oncol18200030843092
   PubMed Web of Science ®Google Scholar
• R.F.OzolsB.N.BundyB.E.GreerJ.M.FowlerPhase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group studyJ Clin Oncol121200331943200
   Google Scholar
• W.P.McGuireW.J.HoskinsM.F.BradyP.R.KuceraCyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancerN Engl J Med4:3341199616
   Web of Science ®Google Scholar
• F.M.MuggiaP.S.BralyM.F.BradyPhase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group studyJ Clin Oncol1812000106115
   PubMed Web of Science ®Google Scholar
• T.HögbergB.GlimeliusP.NygrenSBU-group Swedish Council of Technology assessment in health care. a systematic overview of chemotherapy effects in ovarian cancerActa Oncol.402–32001340360
   Web of Science ®Google Scholar
• S.TangjitgamolH.T.SeeS.ManusirivithayaThird-line chemotherapy in platinum and paclitaxel resistant ovarian, fallopian tube, and primary peritoneal carcinoma patientsInt J Gynecol Cancer1452004804814
   Web of Science ®Google Scholar
• S.NishioN.KatsumataK.MatsumotoH.TanabeK.YonemoriT.KounoUsefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapyJ Cancer Res Clin Oncol13542009551557
   Web of Science ®Google Scholar